Promoter holding
64.27%
AP
Akash Pharma Pvt Ltd - Due diligence report
A 360° intelligence report on Akash Pharma Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and distress s…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Akash Pharma Pvt Ltd — 360° Intelligence Report
Generated from MCA filings & public records84/100
Trust Score
Low Risk
Akash Pharma Pvt Ltd is assessed as Low Risk with a Trust Score of 84/100. Akash Pharma Pvt Ltd is an active private limited indian non-government company incorporated in 1979, operating in the Healthcare sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 06 Jul 2026 from the latest processed filings. Akash Pharma Pvt Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
84/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 55/100 Moderate
- Negative operating earnings - debt service depends on external support.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 3 open (9.00 Lakh) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Syndicate Bank | 3 | 48.0 cr |
Compliance Score: 93/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 1 court forum(s).
- 1 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| PRADEEP JAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ARIHANT JAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
As per FY 2022 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold the largest single block of equity - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 50 · Distress 65
Growth signals & trust indicators
Profit expanded 38% year-on-year.
Operating for 47+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Outside liabilities up 1.42 in a year.
3 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment69/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 9.00 Lakh already registered.
- Compliance record supports lending.
Investor view66/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 12 events30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
31 Oct 2017
Director ceased
SUDHA DEVI JAIN
28 Oct 2017
Director appointed
ARIHANT JAIN (Director)
04 Jun 2016
Director ceased
AKASH NARULA
Director ceased
EKTA NARULA
Director ceased
KAVITA NARULA
30 Mar 2016
Director appointed
PRADEEP JAIN (Director)
31 Oct 1994
Charge created
Syndicate Bank - 3.00 Lakh
12 Mar 1993
Charge created
Syndicate Bank - 3.00 Lakh
12 Mar 1981
Charge created
Syndicate Bank - 3.00 Lakh
18 May 1979
Incorporated
Registered with Roc Guwahati
10
Key Observations
Auto-generated from the data aboveRevenue declined 2.1x over the last 4 financial year(s).
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold the largest single block of equity as per the FY 2022 annual return.
| Company | CIN | Location |
|---|---|---|
| Himalaya Digital India Private Limited | U74899DL1978PTC009041 | New Delhi, Delhi, India |
| Hempire Green Technology Private Limited | U01110GJ2020PTC113960 | Mahesana, Gujarat, India |
| Gurubhakti Finvest Private Limited | U99999MH2005PTC157962 | Mumbai, Maharashtra, India |
| Cosmic Communications Private Limited | U51395MH1998PTC116708 | Mumbai, Maharashtra, India |
| Yash Builders Private Limited | U45201WB2005PTC101848 | Kolkata, West Bengal, India |
| Jolly Infocom Private Limited | U74999WB2017PTC221615 | Kolkata, West Bengal, India |
| Divine Cell Phones Private Limited | U51909DD2010PTC004683 | Daman, Daman And Diu, India |
| Empower Foods & Beverages Private Limited | U15541DL2006PTC154499 | Delhi, Delhi, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Akash Pharma Pvt Ltd before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Akash Pharma Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Akash Pharma Pvt Ltd - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 84/100, distress signals and MSME payment-delay disclosures - know whether Akash Pharma Pvt Ltd pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Akash Pharma Pvt Ltd - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Akash Pharma Pvt Ltd an active company?
Akash Pharma Pvt Ltd has MCA status “Active” with a compliance score of 93/100 (Low Risk).
Is Akash Pharma Pvt Ltd financially healthy?
Akash Pharma Pvt Ltd has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.
Should I do business with Akash Pharma Pvt Ltd?
Its overall Trust Score is 84/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Akash Pharma Pvt Ltd?
Promoters hold the largest single block of equity - exact percentages are in the full report. 2 active director(s) are on record.
Does Akash Pharma Pvt Ltd have loans or charges against its assets?
3 open charge(s) are registered against its assets.
Is Akash Pharma Pvt Ltd up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).
Is it risky to lend to Akash Pharma Pvt Ltd?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
